{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:04:07Z","timestamp":1754154247708,"version":"3.41.2"},"reference-count":539,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70112585"],"award-info":[{"award-number":["70112585"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.esmogo.2024.100112","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:11:07Z","timestamp":1736176267000},"page":"100112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus\u2014version 4.0"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3228-5138","authenticated-orcid":false,"given":"M.P.","family":"Ebert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hollerbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"H\u00f6ppner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Pech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Vanhoefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6590-8181","authenticated-orcid":false,"given":"C.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Goerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Grenacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Haardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.T.","family":"Knoefel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"K\u00f6rber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9491-3609","authenticated-orcid":false,"given":"R.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7912-0923","authenticated-orcid":false,"given":"P.","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-9339","authenticated-orcid":false,"given":"F.","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lorenzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Meining","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-1410","authenticated-orcid":false,"given":"N.H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nothacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5789-2252","authenticated-orcid":false,"given":"U.","family":"N\u00f6thlings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7519-8897","authenticated-orcid":false,"given":"H.","family":"Schmidberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thuss-Patience","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-378X","authenticated-orcid":false,"given":"J.","family":"Trojan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Weimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Klug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lynen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Porschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmogo.2024.100112_bib1","unstructured":"Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e V. Krebs in Deutschland f\u00fcr 2015\/2016. Available at https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/krebs_in_deutschland_node.html, 2019. Accessed January 12, 2023."},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib2","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ijc.22324","article-title":"Anatomical subsite discrepancy in relation to the impact of the consumption of alcohol, tobacco and betel quid on esophageal cancer","volume":"120","author":"Lee","year":"2007","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/gut.2009.190827","article-title":"Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?","volume":"59","author":"Pandeya","year":"2010","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/EDE.0b013e31821092cd","article-title":"Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis","volume":"22","author":"Tramacere","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.esmogo.2024.100112_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canep.2016.02.001","article-title":"Tobacco and alcohol as risk factors for oesophageal cancer in a high incidence area in South Africa","volume":"41","author":"Sewram","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ajg.2010.449","article-title":"Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden","volume":"106","author":"Zendehdel","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib7","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/ajg.2010.263","article-title":"Long-term esophageal cancer risk in patients with primary achalasia: a prospective study","volume":"105","author":"Leeuwenburgh","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cgh.2006.03.005","article-title":"Familial risk for esophageal cancer: an updated epidemiologic study from Sweden","volume":"4","author":"Ji","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/icvts\/ivs320","article-title":"In patients with corrosive oesophageal stricture for surgery, is oesophagectomy rather than bypass necessary to reduce the risk of oesophageal malignancy?","volume":"15","author":"Okonta","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/gut.2010.233866","article-title":"Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium","volume":"60","author":"Freedman","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/annonc\/mds337","article-title":"Light alcohol drinking and cancer: a meta-analysis","volume":"24","author":"Bagnardi","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2008.12.052","article-title":"Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus","volume":"136","author":"Pandeya","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/annonc\/mdr136","article-title":"A\u00a0meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk","volume":"23","author":"Tramacere","year":"2012","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib14","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3390\/nu13103525","article-title":"Lifestyle, WCRF\/AICR recommendations, and esophageal adenocarcinoma risk: a systematic review of the literature","volume":"13","author":"Nucci","year":"2021","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib15","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/annonc\/mds144","article-title":"Risk of treatment-related esophageal cancer among breast cancer survivors","volume":"23","author":"Morton","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib17","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.21037\/jtd-21-915","article-title":"Long-term radiation therapy-related risk of second primary malignancies in patients with lung cancer","volume":"13","author":"Han","year":"2021","journal-title":"J\u00a0Thorac Dis"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib18","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.3324\/haematol.2014.108258","article-title":"Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma","volume":"99","author":"Morton","year":"2014","journal-title":"Haematologica"},{"issue":"15","key":"10.1016\/j.esmogo.2024.100112_bib19","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/aje\/kwi050","article-title":"Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer","volume":"161","author":"Zablotska","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib21","first-page":"710","article-title":"Koinzidenz von Plattenepithelkarzinomen der Speiser\u00f6hre und Kopf-Hals-Karzinomen: Risiko und Fr\u00fcherkennung (Coincidental squamous cell cancers of the esophagus and head and neck: risk and surveillance","volume":"45","author":"Steinberg","year":"2007","journal-title":"Z\u00a0Gastroenterol"},{"issue":"2-3","key":"10.1016\/j.esmogo.2024.100112_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000094523","article-title":"Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer","volume":"73","author":"Moschler","year":"2006","journal-title":"Digestion"},{"issue":"14","key":"10.1016\/j.esmogo.2024.100112_bib23","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.ejca.2011.03.012","article-title":"Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden","volume":"47","author":"Ljung","year":"2011","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canep.2011.03.001","article-title":"Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets","volume":"35","author":"Ryan","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.esmogo.2024.100112_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2458-9-88","article-title":"The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis","volume":"9","author":"Guh","year":"2009","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/annonc\/mds244","article-title":"A\u00a0meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma","volume":"24","author":"Turati","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.gie.2015.12.036","article-title":"Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett\u2019s esophagus cohort","volume":"84","author":"Krishnamoorthi","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2011-300551","article-title":"A\u00a0prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study","volume":"61","author":"O\u2019Doherty","year":"2012","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib29","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/cncr.22245","article-title":"Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia","volume":"107","author":"Chak","year":"2006","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000065835","article-title":"Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia","volume":"19","author":"Velanovich","year":"2002","journal-title":"Dig Surg"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/cncr.11568","article-title":"Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma","volume":"98","author":"Wu","year":"2003","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib33","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1365-2036.2010.04471.x","article-title":"Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux","volume":"32","author":"Rubenstein","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib34","first-page":"1012","article-title":"Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?","volume":"24","author":"Pandeya","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-15-0323-T","article-title":"The role of gastroesophageal reflux and other factors during progression to esophageal adenocarcinoma","volume":"24","author":"Hazelton","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib36","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.05.007","article-title":"Association between length of Barrett\u2019s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia","volume":"11","author":"Anaparthy","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cgh.2010.11.008","article-title":"Patients with nondysplastic Barrett\u2019s esophagus have low risks for developing dysplasia or esophageal adenocarcinoma","volume":"9","author":"Wani","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.gastro.2013.05.040","article-title":"Persistence of nondysplastic Barrett\u2019s esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort","volume":"145","author":"Gaddam","year":"2013","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.esmogo.2024.100112_bib39","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis","volume":"61","author":"Desai","year":"2012","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1053\/j.gastro.2013.02.050","article-title":"Cause-specific mortality of people with Barrett\u2019s esophagus compared with the general population: a population-based cohort study","volume":"144","author":"Solaymani-Dodaran","year":"2013","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib42","first-page":"1299","article-title":"[S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013]","volume":"52","author":"Koop","year":"2014","journal-title":"Z\u00a0Gastroenterol"},{"issue":"9759","key":"10.1016\/j.esmogo.2024.100112_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/gut.2010.228254","article-title":"Guidelines for the management of oesophageal and gastric cancer","volume":"60","author":"Allum","year":"2011","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004183.pub2","article-title":"Antioxidant supplements for preventing gastrointestinal cancers","author":"Bjelakovic","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib49","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/ijc.21419","article-title":"Occupational physical activity and risk of adenocarcinomas of the esophagus and stomach","volume":"118","author":"Vigen","year":"2006","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ijc.28024","article-title":"Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies","volume":"133","author":"Liu","year":"2013","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib51","first-page":"2744","article-title":"Meat and heme iron intake and esophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study","volume":"133","author":"Jakszyn","year":"2013","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/nure.12028","article-title":"Meat, fish, and esophageal cancer risk: a systematic review and dose-response meta-analysis","volume":"71","author":"Salehi","year":"2013","journal-title":"Nutr Rev"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3748\/wjg.v19.i7.1020","article-title":"Consumption of red and processed meat and esophageal cancer risk: meta-analysis","volume":"19","author":"Choi","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib54","first-page":"193","article-title":"Red and processed meat intake and risk of esophageal adenocarcinoma: a meta-analysis of observational studies","volume":"24","author":"Huang","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib55","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/annonc\/mdr615","article-title":"Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study","volume":"23","author":"Keszei","year":"2012","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib56","first-page":"2453","article-title":"Evaluation and treatment of swallowing impairments","volume":"61","author":"Palmer","year":"2000","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib57","first-page":"432","article-title":"[How safe is sedation in gastrointestinal endoscopy? A multicentre analysis of 388,404 endoscopies and analysis of data from prospective registries of complications managed by members of the Working Group of Leading Hospital Gastroenterologists (ALGK)]","volume":"51","author":"Behrens","year":"2013","journal-title":"Z\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5009\/gnl13401","article-title":"Clinical significance of early detection of esophageal cancer in patients with head and neck cancer","volume":"9","author":"Lim","year":"2015","journal-title":"Gut Liver"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib59","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/lary.23249","article-title":"Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma","volume":"122","author":"Katada","year":"2012","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib60","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/archoto.2009.105","article-title":"Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis","volume":"135","author":"Chow","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0016-5107(02)70436-7","article-title":"Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer","volume":"56","author":"Muto","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib62","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/ajg.2010.489","article-title":"Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer","volume":"106","author":"Hori","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib63","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.cgh.2013.06.017","article-title":"Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett\u2019s esophagus: a meta-analysis and systematic review","volume":"11","author":"Qumseya","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib64","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2010.06.045","article-title":"Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett\u2019s esophagus","volume":"139","author":"Curvers","year":"2010","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"10.1016\/j.esmogo.2024.100112_bib65","first-page":"E2343","article-title":"Image-enhanced endoscopy for detection of second primary neoplasm in patients with esophageal and head and neck cancer: a systematic review and meta-analysis","volume":"38","author":"Chung","year":"2016","journal-title":"Head Neck"},{"issue":"suppl 1","key":"10.1016\/j.esmogo.2024.100112_bib66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1443-1661.2011.01119.x","article-title":"Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: current consensus of experienced endoscopists in Asia-Pacific region","volume":"23","author":"Uedo","year":"2011","journal-title":"Dig Endosc"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib67","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/ajg.2010.171","article-title":"Low-grade dysplasia in Barrett\u2019s esophagus: overdiagnosed and underestimated","volume":"105","author":"Curvers","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib68","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1055\/a-1224-6822","article-title":"Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial","volume":"53","author":"Gruner","year":"2021","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gie.2015.07.023","article-title":"Acetic acid chromoendoscopy for the diagnosis of early neoplasia and specialized intestinal metaplasia in Barrett\u2019s esophagus: a meta-analysis","volume":"83","author":"Coletta","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib70","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.gie.2016.01.007","article-title":"ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillanc","volume":"83","author":"Thosani","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/gutjnl-2011-300962","article-title":"Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett\u2019s oesophagus: a prospective, international, randomised controlled trial","volume":"62","author":"Sharma","year":"2013","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.gie.2013.09.020","article-title":"In\u00a0vivo endomicroscopy improves detection of Barrett\u2019s esophagus-related neoplasia: a multicenter international randomized controlled trial (with video)","volume":"79","author":"Canto","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.esmogo.2024.100112_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4638683","article-title":"Confocal laser endomicroscopy in gastrointestinal and pancreatobiliary diseases: a systematic review and meta-analysis","volume":"2016","author":"Fugazza","year":"2016","journal-title":"Biomed Res Int"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib74","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gutjnl-2018-317573","article-title":"Computer-aided diagnosis using deep learning in the evaluation of early oesophageal adenocarcinoma","volume":"68","author":"Ebigbo","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib75","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.gie.2019.12.049","article-title":"Artificial intelligence using convolutional neural networks for real-time detection of early esophageal neoplasia in Barrett\u2019s esophagus (with video)","volume":"91","author":"Hashimoto","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib76","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2019.11.030","article-title":"Deep-learning system detects neoplasia in patients with Barrett\u2019s esophagus with higher accuracy than endoscopists in a multistep training and validation study with benchmarking","volume":"158","author":"de Groof","year":"2020","journal-title":"Gastroenterology"},{"issue":"39","key":"10.1016\/j.esmogo.2024.100112_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17390","article-title":"Cancer of Oesophagus or Gastricus \u2013 New Assessment of Technology of Endosonography (COGNATE): report of pragmatic randomised trial","volume":"17","author":"Russell","year":"2013","journal-title":"Health Technol Assess"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib78","doi-asserted-by":"crossref","first-page":"e0158373","DOI":"10.1371\/journal.pone.0158373","article-title":"Endoscopic ultrasound for preoperative esophageal squamous cell carcinoma: a meta-analysis","volume":"11","author":"Luo","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib79","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.dld.2018.02.005","article-title":"High\u00a0rate of over-staging of Barrett\u2019s neoplasia with endoscopic ultrasound: systemic review and meta-analysis","volume":"50","author":"Qumseya","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib80","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3748\/wjg.14.1479","article-title":"Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review","volume":"14","author":"Puli","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib81","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.gie.2011.09.016","article-title":"Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis","volume":"75","author":"Thosani","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","article-title":"Staging investigations for oesophageal cancer: a meta-analysis","volume":"98","author":"van Vliet","year":"2008","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib83","article-title":"Stadification initiale du cancer de l\u2019oesophage: revue systematique sur la performance des methodes diagnostiques","volume":"5","author":"Tranchemontagne","year":"2009","journal-title":"ETMIS"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib84","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jtho.2019.04.004","article-title":"Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: a diagnostic systematic review and meta-analysis","volume":"14","author":"de Gouw","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib85","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1470-2045(18)30201-8","article-title":"Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study","volume":"19","author":"Noordman","year":"2018","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/SLA.0000000000003397","article-title":"Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis","volume":"271","author":"Eyck","year":"2020","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib87","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-2008-1027195","article-title":"Sonografische Leberdiagnostik bei Tumorpatienten ohne und mit Kontrastmittel (Baseline and contrast-enhanced ultrasound of the liver in tumor patients)","volume":"29","author":"Oldenburg","year":"2008","journal-title":"Ultraschall Med"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib88","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1148\/radiol.2243011362","article-title":"Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis","volume":"224","author":"Kinkel","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.esmogo.2024.100112_bib89","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2407-7-171","article-title":"Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer","volume":"7","author":"Piscaglia","year":"2007","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib90","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3748\/wjg.v12.i11.1699","article-title":"Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI","volume":"12","author":"Dietrich","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib91","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1148\/radiol.2272011833","article-title":"Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study","volume":"227","author":"Albrecht","year":"2003","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib92","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.clinimag.2010.09.004","article-title":"Screening for liver metastases in women with mammary carcinoma: comparison of contrast-enhanced ultrasound and magnetic resonance imaging","volume":"35","author":"H\u00e4nle","year":"2011","journal-title":"Clin Imaging"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib93","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-0029-1245591","article-title":"Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients","volume":"31","author":"Seitz","year":"2010","journal-title":"Ultraschall Med"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib94","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0028-1109673","volume":"30","author":"Seitz","year":"2009","journal-title":"Ultraschall Med"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib95","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1055\/s-0028-1109672","article-title":"Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS)","volume":"30","author":"Strobel","year":"2009","journal-title":"Ultraschall Med"},{"issue":"16","key":"10.1016\/j.esmogo.2024.100112_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17090","article-title":"Contrast-enhanced ultrasound using SonoVue\u00ae (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver me","volume":"17","author":"Westwood","year":"2013","journal-title":"Health Technol Assess"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s002619900338","article-title":"Ultrasonographic evaluation of the cervical lymph nodes in preoperative staging of esophageal neoplasms","volume":"23","author":"Doldi","year":"1998","journal-title":"Abdom Imaging"},{"year":"2012","series-title":"Clinical Practice Guidelines: Upper Gastrointestinal Cancer\u2014Update. Report 179A Brussels","author":"Lerut","key":"10.1016\/j.esmogo.2024.100112_bib98"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib99","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejrad.2007.06.022","article-title":"Current relevance of cervical ultrasonography in staging cancer of the esophagus and gastroesophageal junction","volume":"67","author":"Schreurs","year":"2008","journal-title":"Eur J Radiol"},{"issue":"783","key":"10.1016\/j.esmogo.2024.100112_bib100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1259\/0007-1285-66-783-203","article-title":"Improved assessment of supraclavicular and abdominal metastases in oesophageal and gastro-oesophageal junction carcinoma with the combination of ultrasound and computed tomography","volume":"66","author":"Van Overhagen","year":"1993","journal-title":"Br J Radiol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib101","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.bjc.6603960","article-title":"Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis","volume":"97","author":"van Vliet","year":"2007","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000193630","article-title":"Additional value of external ultrasonography of the neck after CT and PET scanning in the preoperative assessment of patients with esophageal cancer","volume":"26","author":"Omloo","year":"2009","journal-title":"Dig Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib103","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01888575","article-title":"Assessment of distant metastases with ultrasound-guided fine-needle aspiration biopsy and cytologic study in carcinoma of the esophagus and gastroesophageal junction","volume":"17","author":"van Overhagen","year":"1992","journal-title":"Gastrointest Radiol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1148\/radiology.179.1.2006268","article-title":"Supraclavicular lymph node metastases in carcinoma of the esophagus and gastroesophageal junction: assessment with CT, US, and US-guided fine-needle aspiration biopsy","volume":"179","author":"van Overhagen","year":"1991","journal-title":"Radiology"},{"issue":"Special issue A","key":"10.1016\/j.esmogo.2024.100112_bib105","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1102\/1470-7330.2009.9031","article-title":"Thoracic complications and emergencies in oncologic patients","volume":"9","author":"Quint","year":"2009","journal-title":"Cancer Imaging"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib106","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/000313481307900719","article-title":"Water as a contrast medium: a re-evaluation using the multidetector-row computed tomography","volume":"79","author":"Makarawo","year":"2013","journal-title":"Am Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib107","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00130404-200403000-00006","article-title":"Recent advances in CT imaging of liver metastases","volume":"10","author":"Kamel","year":"2004","journal-title":"Cancer J"},{"key":"10.1016\/j.esmogo.2024.100112_bib108","unstructured":"Network S.I.G. Scottish Intercollegiate Guidelines Network Management of Oesophageal and Gastric Cancer. A national clinical guideline; 2006. Available at http:\/\/www.sign.ac.uk\/assets\/qrg115.pdf. Accessed January 12, 2023."},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib109","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2214\/ajr.184.2.01840487","article-title":"Pelvic CT in patients with esophageal cancer","volume":"184","author":"Gollub","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib110","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s00330-011-2187-2","article-title":"Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results","volume":"21","author":"Ba-Ssalamah","year":"2011","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib111","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1440-1746.2009.05927.x","article-title":"Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography","volume":"24","author":"Takizawa","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib112","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00464-009-0783-x","article-title":"Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer","volume":"24","author":"Choi","year":"2010","journal-title":"Surg Endosc"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib113","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11307-005-0017-0","article-title":"Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer","volume":"7","author":"Lowe","year":"2005","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib114","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2214\/ajr.174.6.1741551","article-title":"Comparing MR imaging and CT in the staging of gastric carcinoma","volume":"174","author":"Sohn","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib115","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11547-009-0455-x","article-title":"Diagnostic performance of 64-MDCT and 1.5-T MRI with high-resolution sequences in the T staging of gastric cancer: a comparative analysis with histopathology","volume":"114","author":"Anzidei","year":"2009","journal-title":"Radiol Med"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1148\/radiol.2331030777","article-title":"Whole-body MR imaging: evaluation of patients for metastases","volume":"233","author":"Lauenstein","year":"2004","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0147-0272(00)80002-1","article-title":"Esophageal cancer: a systematic review","volume":"24","author":"Wong","year":"2000","journal-title":"Curr Probl Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib118","first-page":"45","article-title":"Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET\/CT in monitoring early\u00a0response to neoadjuvant chemotherapy in adenocarcinoma of the\u00a0esophagogastric junction","volume":"22","author":"Weber","year":"2013","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"issue":"Spec Iss A","key":"10.1016\/j.esmogo.2024.100112_bib119","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1102\/1470-7330.2008.9007","article-title":"Staging esophageal cancer","volume":"8","author":"Quint","year":"2008","journal-title":"Cancer Imaging"},{"issue":"18","key":"10.1016\/j.esmogo.2024.100112_bib120","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2000.18.18.3202","article-title":"Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma","volume":"18","author":"Flamen","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib121","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1200\/JCO.2003.04.013","article-title":"Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial","volume":"21","author":"Downey","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib122","first-page":"980","article-title":"Detection of distant metastases in esophageal cancer with (18)F-FDG PET","volume":"45","author":"Heeren","year":"2004","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib123","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.athoracsur.2009.02.065","article-title":"Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma","volume":"87","author":"Hsu","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib124","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2967\/jnumed.111.101568","article-title":"18F-FDG PET\/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data","volume":"53","author":"Barber","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.athoracsur.2013.02.069","article-title":"The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer","volume":"96","author":"Varghese","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"50","key":"10.1016\/j.esmogo.2024.100112_bib126","doi-asserted-by":"crossref","first-page":"e13722","DOI":"10.1097\/MD.0000000000013722","article-title":"Diagnostic value of 18F-fluorodeoxyglucose positron-emission tomography\/computed tomography for preoperative lymph node metastasis of esophageal cancer: a meta-analysis","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib127","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.21037\/jtd.2018.10.57","article-title":"Systematic review and meta-analysis of the accuracy of 18F-FDG PET\/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma","volume":"10","author":"Jiang","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib128","first-page":"326","article-title":"[Is bronchoscopy a useful additional preoperative examination in esophageal carcinoma?]","volume":"375","author":"Imadahl","year":"1990","journal-title":"Langenbecks Arch Chir"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib129","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1159\/000093160","article-title":"Usefulness of preoperative endobronchial ultrasound for airway invasion around the trachea: esophageal cancer and thyroid cancer","volume":"73","author":"Wakamatsu","year":"2006","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00268-003-6784-3","article-title":"Bronchoscopic ultrasonography for staging supracarinal esophageal squamous cell carcinoma: impact on outcome","volume":"27","author":"Osugi","year":"2003","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib132","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/bjs.9905","article-title":"Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy","volume":"102","author":"Findlay","year":"2015","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib133","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/gut.2004.046631","article-title":"Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population","volume":"54","author":"Wang","year":"2005","journal-title":"Gut"},{"year":"2010","series-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","key":"10.1016\/j.esmogo.2024.100112_bib134"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0046-8177(88)80344-7","article-title":"Observer variation in the diagnosis of dysplasia in Barrett\u2019s esophagus","volume":"19","author":"Reid","year":"1988","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib136","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1111\/j.1572-0241.2000.03348.x","article-title":"The diagnosis of low-grade dysplasia in Barrett\u2019s esophagus and its implications for disease progression","volume":"95","author":"Skacel","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib137","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/hupa.2001.23510","article-title":"Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation","volume":"32","author":"Montgomery","year":"2001","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib138","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.51.5.671","article-title":"Observer variation in the diagnosis of superficial oesophageal adenocarcinoma","volume":"51","author":"Ormsby","year":"2002","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib139","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","article-title":"Grading of dysplasia in Barrett\u2019s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists","volume":"50","author":"Kerkhof","year":"2007","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cgh.2010.04.028","article-title":"Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett\u2019s dysplasia","volume":"8","author":"Wani","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib141","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0042-122140","article-title":"Endoscopic management of Barrett\u2019s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement","volume":"49","author":"Weusten","year":"2017","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib142","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ajg.2015.322","article-title":"ACG Clinical Guideline: diagnosis and management of Barrett\u2019s esophagus","volume":"111","author":"Shaheen","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib143","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1572-0241.2007.01230.x","article-title":"Detection of intestinal metaplasia in Barrett\u2019s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies","volume":"102","author":"Harrison","year":"2007","journal-title":"Am J Gastroenterol"},{"year":"2020","series-title":"TNM Klassifikation Maligner Tumoren","author":"Wittekind","key":"10.1016\/j.esmogo.2024.100112_bib144"},{"year":"2021","series-title":"TNM Atlas: Illustrated Guide to the TNM Classification of Malignant Tumours","author":"Brierley","key":"10.1016\/j.esmogo.2024.100112_bib145"},{"year":"1977","series-title":"International Classification of Diseases for Oncology (ICD-O)","author":"Percy","key":"10.1016\/j.esmogo.2024.100112_bib146"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib147","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0039-6060(98)70165-5","article-title":"Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan","volume":"123","author":"Kodama","year":"1998","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib148","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jso.20569","article-title":"Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?","volume":"94","author":"Bollschweiler","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib149","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0003-4975(97)01387-8","article-title":"Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status","volume":"65","author":"Rice","year":"1998","journal-title":"Ann Thorac Surg"},{"year":"2008","series-title":"The American Heritage Medical Dictionary","key":"10.1016\/j.esmogo.2024.100112_bib150"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib151","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","article-title":"Classification of adenocarcinoma of the oesophagogastric junction","volume":"85","author":"Siewert","year":"1998","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib152","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib153","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib154","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2009.123","article-title":"Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas","volume":"22","author":"Langer","year":"2009","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib155","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/SLA.0b013e318216f449","article-title":"Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases","volume":"253","author":"Becker","year":"2011","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/519351","article-title":"Assessment of histopathological response in gastric and gastro-oesophageal junction adenocarcinoma following neoadjuvant chemotherapy: which scoring system to use?","volume":"2012","author":"Mirza","year":"2012","journal-title":"ISRN Pathol"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib157","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H","volume":"91","author":"Ancona","year":"2001","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib158","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/cncr.21439","article-title":"Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response","volume":"104","author":"Rohatgi","year":"2005","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib159","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.sla.0000186170.38348.7b","article-title":"Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification","volume":"242","author":"Schneider","year":"2005","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-009-0862-1","article-title":"Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer","volume":"17","author":"Meredith","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib161","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cncr.20916","article-title":"Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation","volume":"103","author":"Chirieac","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib162","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/his.13491","article-title":"Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy \u2013 results from the MRC OE02 oesophageal cancer trial","volume":"72","author":"Davarzani","year":"2018","journal-title":"Histopathology"},{"issue":"23","key":"10.1016\/j.esmogo.2024.100112_bib163","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1200\/JCO.2015.65.7692","article-title":"Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial","volume":"34","author":"Smyth","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.esmogo.2024.100112_bib164","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2014.55.9070","article-title":"Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction","volume":"32","author":"Davies","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"9742","key":"10.1016\/j.esmogo.2024.100112_bib165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib166","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1634\/theoncologist.2014-0058","article-title":"Quality of life in the trastuzumab for gastric cancer trial","volume":"19","author":"Satoh","year":"2014","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib167","first-page":"45","article-title":"[Significance of preoperative weight loss for perioperative metabolic adaptation and surgical risk in patients with tumors of the upper gastrointestinal tract]","volume":"377","author":"Weimann","year":"1992","journal-title":"Langenbecks Arch Chir"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib168","first-page":"117","article-title":"Factors related to malnutrition in patients with esophageal cancer","volume":"7","author":"Saito","year":"1991","journal-title":"Nutrition"},{"year":"2014","series-title":"Die Wertigkeit der Feinnadelkatheterjejunostomie in der postoperativen enteralen Ern\u00e4hrung nach \u00d6sophagusresektion Deutsche Gesellschaft f\u00fcr Chirurgie 131 Kongress der Dt Gesellschaft f\u00fcr Chirurgie Berlin 25-28032014","key":"10.1016\/j.esmogo.2024.100112_bib169"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0148607112445900","article-title":"Preoperative nutrition status and postoperative outcome in elderly general surgery patients: a systematic review","volume":"37","author":"van Stijn","year":"2013","journal-title":"J\u00a0Parenter Enteral Nutr"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib171","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00104-014-2737-7","article-title":"Klinische Ern\u00e4hrung in der Chirurgie","volume":"85","author":"Weimann","year":"2014","journal-title":"Chirurg"},{"key":"10.1016\/j.esmogo.2024.100112_bib172","unstructured":"Arends J. S3-Leitlinie der Deutschen Gesellschaft f\u00fcr Ern\u00e4hrungsmedizin. Klinische Ern\u00e4hrung in der nicht-chirurgischen Onkologie; 2015. Available at https:\/\/www.dgem.de\/sites\/default\/files\/PDFs\/Leitlinien\/S3-Leitlinien\/073-006l_S3_Klin_Ern\u00e4hrung_in_der_Onkologie_2015-10.pdf. Accessed January 12, 2023."},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib173","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/SLA.0b013e31821d4bf6","article-title":"Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett\u2019s esophagus at two high-volume centers","volume":"254","author":"Pech","year":"2011","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib174","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.gastro.2009.05.059","article-title":"Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett\u2019s esophagus","volume":"137","author":"Prasad","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0016-5107(02)99993-1","article-title":"Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett\u2019s esophagus","volume":"55","author":"Sharma","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib176","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2006.04.033","article-title":"Curative endoscopic resection of early esophageal adenocarcinomas (Barrett\u2019s cancer)","volume":"65","author":"Ell","year":"2007","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib177","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/gut.2007.142539","article-title":"Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett\u2019s oesophagus","volume":"57","author":"Pech","year":"2008","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib178","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/ajg.2009.465","article-title":"Complete Barrett\u2019s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma \u2013 an American single-center experience","volume":"104","author":"Chennat","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib179","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/ajg.2010.1","article-title":"Endoscopic resection for Barrett\u2019s high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit","volume":"105","author":"Moss","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib180","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.2010.210229","article-title":"Stepwise radical endoscopic resection for eradication of Barrett\u2019s oesophagus with early neoplasia in a cohort of 169 patients","volume":"59","author":"Pouw","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib181","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cgh.2009.07.003","article-title":"Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett\u2019s esophagus with early neoplasia","volume":"8","author":"Pouw","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib182","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/gut.2010.229310","article-title":"Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett\u2019s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial","volume":"60","author":"Van Vilsteren","year":"2011","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib183","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/j.1572-0241.2008.02083.x","article-title":"Early Barrett\u2019s carcinoma with \u201clow-risk\u201d submucosal invasion: long-term results of endoscopic resection\u00a0with a curative intent","volume":"103","author":"Manner","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib184","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cgh.2012.12.040","article-title":"Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion","volume":"11","author":"Manner","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib185","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1055\/s-0030-1255858","article-title":"Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens","volume":"42","author":"Alvarez Herrero","year":"2010","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib186","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus","volume":"63","author":"Fitzgerald","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib187","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2013.11.006","article-title":"Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus","volume":"146","author":"Pech","year":"2014","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.esmogo.2024.100112_bib188","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.3748\/wjg.v20.i18.5540","article-title":"Endoscopic submucosal dissection vs endoscopic mucosal resection for superficial esophageal cancer","volume":"20","author":"Guo","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib189","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1055\/s-0032-1310155","article-title":"Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barretts esophagus","volume":"44","author":"Neuhaus","year":"2012","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.gie.2014.01.022","article-title":"Clinical outcomes of endoscopic submucosal dissection for superficial Barrett\u2019s adenocarcinoma","volume":"80","author":"Kagemoto","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib191","first-page":"K233","article-title":"Endoskopische Submukosadissektion (ESD) im \u00d6sophagus","volume":"51","author":"Probst","year":"2013","journal-title":"Z\u00a0Gastroenterol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib192","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/00042737-200210000-00009","article-title":"Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett\u2019s oesophagus: acute-phase and intermediate results of a new treatment approach","volume":"14","author":"May","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib193","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0016-5085(98)70527-X","article-title":"Photodynamic ablation of high-grade dysplasia and early cancer in Barrett\u2019s esophagus by means of 5-aminolevulinic acid","volume":"114","author":"Gossner","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib194","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0016-5107(05)00333-0","article-title":"Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett\u2019s cancer and high-grade intraepithelial neoplasia","volume":"62","author":"Pech","year":"2005","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib195","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.gie.2006.12.037","article-title":"Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett\u2019s high-grade dysplasia","volume":"66","author":"Overholt","year":"2007","journal-title":"Gastrointest Endosc"},{"issue":"22","key":"10.1016\/j.esmogo.2024.100112_bib196","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","article-title":"Radiofrequency ablation in Barrett\u2019s esophagus with dysplasia","volume":"360","author":"Shaheen","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib197","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2011.04.061","article-title":"Durability of radiofrequency ablation in Barrett\u2019s esophagus with dysplasia","volume":"141","author":"Shaheen","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib198","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gie.2007.12.015","article-title":"Circumferential ablation of Barrett\u2019s esophagus that contains high-grade dysplasia: a U.S. multicenter registry","volume":"68","author":"Ganz","year":"2008","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib199","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2013.03.046","article-title":"Remission of Barrett\u2019s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study","volume":"145","author":"Phoa","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ajg.2012.413","article-title":"Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett\u2019s Esophagus with radiofrequency ablation","volume":"108","author":"Orman","year":"2013","journal-title":"Ame J Gastroenterol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib201","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2001-12803","article-title":"Argon plasma coagulation in the treatment of Barrett\u2019s high-grade dysplasia and in situ adenocarcinoma","volume":"33","author":"Van Laethem","year":"2001","journal-title":"Endoscopy"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib202","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/00365520510015737","article-title":"Endoscopic ablation of dysplastic Barrett\u2019s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness","volume":"40","author":"Ragunath","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"11-12","key":"10.1016\/j.esmogo.2024.100112_bib203","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1365-2036.2004.02277.x","article-title":"Endoscopic ablation of Barrett\u2019s oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation","volume":"20","author":"Kelty","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib204","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.gie.2009.02.006","article-title":"An open-label, prospective trial of cryospray ablation for Barrett\u2019s esophagus high-grade dysplasia and early esophageal cancer in high-risk patients","volume":"70","author":"Dumot","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib205","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.gie.2010.01.018","article-title":"Safety and efficacy of endoscopic spray cryotherapy for Barrett\u2019s esophagus with high-grade dysplasia","volume":"71","author":"Shaheen","year":"2010","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib206","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.gie.2008.03.1114","article-title":"Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan","volume":"68","author":"Ishihara","year":"2008","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib207","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/s-0029-1215053","article-title":"Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract","volume":"41","author":"Cao","year":"2009","journal-title":"Endoscopy"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib208","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1572-0241.2007.01073.x","article-title":"Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett\u2019s esophagus","volume":"102","author":"Srivastava","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib209","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.2014.2511","article-title":"Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia","volume":"311","author":"Phoa","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ctrv.2010.04.006","article-title":"The safety and effectiveness of endoscopic and non-endoscopic approaches to the management of early esophageal cancer: a systematic review","volume":"37","author":"McCann","year":"2011","journal-title":"Cancer Treat Rev"},{"issue":"36","key":"10.1016\/j.esmogo.2024.100112_bib211","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.3748\/wjg.v19.i36.6011","article-title":"Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry","volume":"19","author":"Haidry","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib212","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0033-1344025","article-title":"Feasibility and efficacy of argon plasma coagulation for early esophageal squamous cell neoplasia","volume":"45","author":"Min","year":"2013","journal-title":"Endoscopy"},{"issue":"38","key":"10.1016\/j.esmogo.2024.100112_bib213","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.3748\/wjg.v18.i38.5412","article-title":"Argon plasma coagulation for superficial esophageal squamous-cell carcinoma in high-risk patients","volume":"18","author":"Tahara","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib214","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0016-5107(05)00063-5","article-title":"Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett\u2019s esophagus","volume":"61","author":"Peters","year":"2005","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib215","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0016-5085(00)70136-3","article-title":"Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett\u2019s esophagus","volume":"118","author":"Ell","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib216","first-page":"412","article-title":"High-volume centers - effect of case load on outcome in cancer surgery","volume":"27","author":"H\u00f6lscher","year":"2004","journal-title":"Onkologie"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib217","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/gutjnl-2013-306074","article-title":"Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis","volume":"63","author":"Brusselaers","year":"2014","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib218","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2012.46.1517","article-title":"Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study","volume":"31","author":"Derogar","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib219","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/SLA.0000000000000248","article-title":"Strategies for reducing regional variation in the use of surgery: a systematic review","volume":"259","author":"Reames","year":"2014","journal-title":"Ann Surg"},{"issue":"47","key":"10.1016\/j.esmogo.2024.100112_bib220","first-page":"793","article-title":"Hospital volume, in-hospital mortality, and failure to rescue in esophageal surgery","volume":"115","author":"Nimptsch","year":"2018","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib221","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00423-006-0067-z","article-title":"Preoperative risk analysis \u2013 a reliable predictor of postoperative outcome after transthoracic esophagectomy?","volume":"391","author":"Schr\u00f6der","year":"2006","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib222","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1046\/j.1365-2168.2000.01474.x","article-title":"Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus","volume":"87","author":"Bollschweiler","year":"2000","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib223","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/bjs.5850","article-title":"Evaluation of O-POSSUM in predicting in-hospital mortality after resection for oesophageal cancer","volume":"94","author":"Lagarde","year":"2007","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib224","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.athoracsur.2013.05.051","article-title":"Assessment of morbidity and mortality after esophagectomy using a modified frailty index","volume":"96","author":"Hodari","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ctrv.2011.10.005","article-title":"Radiotherapy versus surgery within multimodality protocols for esophageal cancer - a meta-analysis of the randomized trials","volume":"38","author":"P\u00f6ttgen","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib226","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1245\/s10434-013-3364-0","article-title":"Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis","volume":"21","author":"Markar","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"suppl 3","key":"10.1016\/j.esmogo.2024.100112_bib227","first-page":"S341","article-title":"Salvage esophagectomy","volume":"6","author":"Hofstetter","year":"2014","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib228","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.athoracsur.2013.10.043","article-title":"Prognostic significance of positive circumferential resection margin in esophageal cancer: a systematic review and meta-analysis","volume":"97","author":"Wu","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib229","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00104-003-0649-z","article-title":"How safe is high intrathoracic esophagogastrostomy?","volume":"74","author":"H\u00f6lscher","year":"2003","journal-title":"Chirurg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib230","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/SLA.0b013e3181640276","article-title":"Re: Laparoscopic ischemic conditioning of the stomach for esophageal replacement","volume":"247","author":"Parameswaran","year":"2008","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib231","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamasurg.2014.2877","article-title":"Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial","volume":"150","author":"Li","year":"2015","journal-title":"JAMA Surg"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib232","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s11605-008-0612-x","article-title":"Response-the resection of the azygos vein-necessary or redundant extension of transthoracic esophagectomy","volume":"12","author":"Schroeder","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib233","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1442-2050.2007.00760.x","article-title":"The effect of azygos vein preservation on mediastinal lymph node harvesting in thoracic esophagolymphadenectomy","volume":"21","author":"Boone","year":"2008","journal-title":"Dis Esophagus"},{"year":"1973","series-title":"TNM Klassifikation Maligner Tumoren","author":"Harmer","key":"10.1016\/j.esmogo.2024.100112_bib234"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib235","first-page":"25","article-title":"[Cardia cancer: attempt at a therapeutically relevant classification]","volume":"58","author":"Siewert","year":"1987","journal-title":"Chirurg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib236","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/SLA.0000000000000335","article-title":"What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy","volume":"260","author":"Kutup","year":"2014","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib237","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/SLA.0b013e31815c4037","article-title":"Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid\/distal esophagus: five-year survival of a randomized clinical trial","volume":"246","author":"Omloo","year":"2007","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib238","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.athoracsur.2016.07.010","article-title":"Improved functional results after minimally invasive esophagectomy: intrathoracic versus cervical anastomosis","volume":"103","author":"van Workum","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.esmogo.2024.100112_bib239","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.2147\/OTT.S169488","article-title":"Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis","volume":"11","author":"Deng","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/SLA.0000000000002611","article-title":"Benchmarking complications associated with esophagectomy","volume":"269","author":"Low","year":"2019","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib241","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SLA.0000000000001098","article-title":"International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG)","volume":"262","author":"Low","year":"2015","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib242","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/bjs.10728","article-title":"Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer","volume":"105","author":"Gooszen","year":"2018","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib243","first-page":"131","article-title":"Circular stapling versus triangulating stapling for the cervical esophagogastric anastomosis after esophagectomy in patients with thoracic esophageal cancer: a prospective, randomized, controlled trial","volume":"162","author":"Hayata","year":"2017","journal-title":"Surgery (United States)"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib244","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1470-2045(06)70766-5","article-title":"Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial","volume":"7","author":"Sasako","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib245","doi-asserted-by":"crossref","first-page":"341","DOI":"10.21037\/tgh.2016.03.08","article-title":"A\u00a0commentary on \u201cTen-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.\u201d","volume":"1","author":"Mine","year":"2016","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib246","first-page":"129","article-title":"Neue S3-Leitlinie zur Diagnostik und Therapie der Adenokarzinome des Magens und des \u00f6sophagogastralen \u00dcbergangs","volume":"28","author":"Andus","year":"2012","journal-title":"Viszeral Gastrointest Med Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib247","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/SLA.0000000000002280","article-title":"Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial","volume":"267","author":"Li","year":"2018","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib248","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/SLA.0b013e318188c474","article-title":"The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection","volume":"248","author":"Peyre","year":"2008","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib249","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/SLA.0b013e3181904f3c","article-title":"Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes","volume":"248","author":"Peyre","year":"2008","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib250","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/01.sla.0000145925.70409.d7","article-title":"Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma","volume":"240","author":"Lerut","year":"2004","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib251","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/SLA.0b013e3181b2f6ee","article-title":"Optimum lymphadenectomy for esophageal cancer","volume":"251","author":"Rizk","year":"2010","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib252","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00268-003-6913-z","article-title":"Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy","volume":"27","author":"Fujita","year":"2003","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib253","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doab021","article-title":"Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis","volume":"35","author":"Hagens","year":"2022","journal-title":"Dis Esophagus"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib254","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1245\/s10434-010-1196-8","article-title":"Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer","volume":"17","author":"Bollschweiler","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.athoracsur.2013.09.010","article-title":"The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma","volume":"97","author":"Bekkar","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-018-0868-0","article-title":"Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma","volume":"22","author":"Mariette","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.esmogo.2024.100112_bib257","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10120-016-0663-8","article-title":"Results of a nationwide retrospective study of lymphadenectomy for esophagogastric junction carcinoma","volume":"20","author":"Yamashita","year":"2017","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib258","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/SLA.0000000000003499","article-title":"Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study","volume":"274","author":"Kurokawa","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib259","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10120-019-01022-x","article-title":"Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E\u00a0= G and GE cancers","volume":"23","author":"H\u00f6lscher","year":"2020","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00423-018-1743-5","article-title":"Comparison of double-flap and OrVil techniques of laparoscopy-assisted proximal gastrectomy in preventing gastroesophageal reflux: a retrospective cohort study","volume":"404","author":"Hosoda","year":"2019","journal-title":"Langenbecks Arch Surg"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib261","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00268-014-2624-x","article-title":"Quality of life after surgical treatment of early Barrett\u2019s cancer: a prospective comparison of the Ivor-Lewis resection versus the modified Merendino resection. A statistical hint","volume":"38","author":"Mangano","year":"2014","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib262","first-page":"610","article-title":"Double tract reconstruction following limited oesophagogastric resection of AEG types II and III adenocarcinomas","volume":"41","author":"H\u00f6lscher","year":"2020","journal-title":"Tumor Diagn Ther"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib263","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1186\/s12885-021-08780-x","article-title":"Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)","volume":"21","author":"Tagkalos","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib264","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00268-010-0403-x","article-title":"Ivor-lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit","volume":"34","author":"Schr\u00f6der","year":"2010","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000064206","article-title":"Pyloric drainage (pyloroplasty) or no drainage in gastric reconstruction after esophagectomy: a meta-analysis of randomized controlled trials","volume":"19","author":"Urschel","year":"2002","journal-title":"Dig Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib266","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/dote.12035","article-title":"Should we continue to drain the pylorus in patients undergoing an esophagectomy?","volume":"27","author":"Gaur","year":"2014","journal-title":"Dis Esophagus"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib267","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy097","article-title":"Preoperative endoscopic pyloric balloon dilatation decreases the rate of delayed gastric emptying after Ivor-Lewis esophagectomy","volume":"32","author":"Hadzijusufovic","year":"2019","journal-title":"Dis Esophagus"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib268","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.athoracsur.2007.07.009","article-title":"Diaphragmatic hernia after conventional or laparoscopic-assisted transthoracic esophagectomy","volume":"84","author":"Vallb\u00f6hmer","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib269","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.athoracsur.2012.11.045","article-title":"A\u00a0comprehensive review of anastomotic technique in 432 esophagectomies","volume":"95","author":"Price","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib270","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s00464-015-4299-2","article-title":"Laparoscopic repair of hiatal hernia after minimally invasive esophagectomy","volume":"30","author":"Ulloa","year":"2016","journal-title":"Surg Endosc"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib271","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00268-015-3100-y","article-title":"Quality of life and late complications after minimally invasive compared to open esophagectomy: results of a randomized trial","volume":"39","author":"Maas","year":"2015","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib272","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.athoracsur.2018.08.039","article-title":"Does the approach matter? Comparing survival in robotic, minimally invasive, and open esophagectomies","volume":"107","author":"Espinoza-Mercado","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib273","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/SLA.0000000000002171","article-title":"Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial","volume":"266","author":"Straatman","year":"2017","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib274","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0b013e3182590603","article-title":"Outcomes after minimally invasive esophagectomy: review of over 1000 patients","volume":"256","author":"Luketich","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib275","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.sla.0000225093.58071.c6","article-title":"Comparison of the outcomes between open and minimally invasive esophagectomy","volume":"245","author":"Smithers","year":"2007","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib276","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/bjs.8931","article-title":"Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications","volume":"99","author":"Briez","year":"2012","journal-title":"Br J Surg"},{"issue":"3-4","key":"10.1016\/j.esmogo.2024.100112_bib277","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1024\/0040-5930\/a001346","article-title":"Minimally invasive esophagectomy for esophageal cancer","volume":"79","author":"Berlth","year":"2022","journal-title":"Therapeutische Umschau"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib278","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4251\/wjgo.v11.i11.1081","article-title":"Efficacy of hybrid minimally invasive esophagectomy vs open esophagectomy for esophageal cancer: a\u00a0meta-analysis","volume":"11","author":"Yang","year":"2019","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib279","doi-asserted-by":"crossref","first-page":"E744","DOI":"10.1097\/SLA.0000000000004645","article-title":"Long-term survival in esophageal cancer after minimally invasive esophagectomy compared to open esophagectomy","volume":"276","author":"Gottlieb-Vedi","year":"2022","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib280","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.surg.2015.08.019","article-title":"Early outcome of thoracoscopic and hybrid esophagectomy: propensity-matched comparative analysis","volume":"159","author":"Bonavina","year":"2016","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib281","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00464-016-4938-2","article-title":"Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers","volume":"31","author":"Straatman","year":"2017","journal-title":"Surg Endosc"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib282","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/SLA.0000000000002868","article-title":"Comment on \u201cA propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands.\u201d","volume":"269","author":"Meunier","year":"2019","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib283","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/SLA.0000000000003006","article-title":"Comment on \u201cDefining benchmarks for transthoracic esophagectomy: a multicenter analysis of total minimally invasive esophagectomy in low-risk patients.\u201d","volume":"270","author":"Helminen","year":"2019","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib284","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1245\/s10434-014-4079-6","article-title":"Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt? Esophagectomy outcomes of patients with suspicious metastatic lesions","volume":"22","author":"Erhunmwunsee","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib285","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s00268-013-2074-x","article-title":"Induction chemotherapy or chemoradiotherapy followed by radical esophagectomy for T4 esophageal cancer: results of a prospective cohort study","volume":"37","author":"Shimoji","year":"2013","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib286","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","article-title":"The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III tri","volume":"17","author":"Al-Batran","year":"2017","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib287","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4251\/wjgo.v11.i9.741","article-title":"Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: a systematic review","volume":"11","author":"Jamel","year":"2019","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2006.01.015","article-title":"ESPEN Guidelines on Enteral Nutrition: surgery including organ transplantation","volume":"25","author":"Weimann","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.esmogo.2024.100112_bib289","unstructured":"Weimann A. S3-Leitlinie der Deutschen Gesellschaft f\u00fcr Ern\u00e4hrungsmedizin: Klinische Ern\u00e4hrung in der Chirurgie. Aktuell Ern\u00e4hrungsmedizin. 38:e155-e1."},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib290","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0261-5614(03)00098-0","article-title":"ESPEN guidelines for nutrition screening 2002","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib291","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/bjs.6805","article-title":"Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer","volume":"97","author":"Schwegler","year":"2010","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib292","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clnu.2008.03.012","article-title":"EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome","volume":"27","author":"Sorensen","year":"2008","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib293","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nut.2012.06.013","article-title":"Nutritional screening for risk prediction in patients scheduled for extra-abdominal surgery","volume":"29","author":"Kuppinger","year":"2013","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib294","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/SLA.0b013e318230631b","article-title":"Reply: Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery","volume":"254","author":"Hennessey","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ncp.10588","article-title":"The use of visceral proteins as nutrition markers: an ASPEN position paper","volume":"36","author":"Evans","year":"2021","journal-title":"Nutr Clin Pract"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib296","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ejso.2020.04.008","article-title":"A\u00a0systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection","volume":"46","author":"Deftereos","year":"2020","journal-title":"Eur J Sur Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib297","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/dote.12008","article-title":"Dietician-delivered intensive nutritional support is associated with a decrease in severe postoperative complications after surgery in patients with esophageal cancer","volume":"26","author":"Ligthart-Melis","year":"2013","journal-title":"Dis Esophagus"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib298","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1055\/s-0033-1344023","article-title":"Prospective evaluation of malignant cell seeding after percutaneous endoscopic gastrostomy in patients with oropharyngeal\/esophageal cancers","volume":"45","author":"Ellrichmann","year":"2013","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib299","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijsu.2012.12.012","article-title":"Enteral immunonutrition versus standard enteral nutrition for patients undergoing oesophagogastric resection for cancer","volume":"11","author":"Mabvuure","year":"2013","journal-title":"Int J Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib300","doi-asserted-by":"crossref","first-page":"E703","DOI":"10.1097\/SLA.0000000000003840","article-title":"Comment on \u201cThe impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis.\u201d","volume":"274","author":"Doig","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib301","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00104-014-2737-7","article-title":"Clinical nutrition in surgery: guidelines of the German Society for Nutritional Medicine","volume":"85","author":"Weimann","year":"2014","journal-title":"Chirurg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib302","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0261-5614(94)90021-3","article-title":"Impact of nutritional support on the clinical outcome of the surgical patient","volume":"13","author":"Hill","year":"1994","journal-title":"Clin Nutr"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib303","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10151-014-1205-1","article-title":"Pre-operative nutrition support in patients undergoing gastrointestinal surgery","volume":"18","author":"Horgan","year":"2014","journal-title":"Tech Coloproctol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib304","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/014860710002400107","article-title":"Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial","volume":"24","author":"Bozzetti","year":"2000","journal-title":"J\u00a0Parenter Enteral Nutr"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib305","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199108223250801","article-title":"Perioperative total parenteral nutrition in surgical patients","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib306","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.clnu.2021.07.012","article-title":"ESPEN practical guideline: clinical nutrition in surgery","volume":"40","author":"Zhang","year":"2021","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib307","first-page":"CD004080","article-title":"Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for postoperative complications","author":"Andersen","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib308","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11605-008-0592-x","article-title":"Early enteral nutrition within 24 h of intestinal surgery versus later commencement of feeding: a systematic review and meta-analysis","volume":"13","author":"Lewis","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib309","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0148607110385698","article-title":"Early versus traditional postoperative feeding in patients undergoing resectional gastrointestinal surgery: a meta-analysis","volume":"35","author":"Osland","year":"2011","journal-title":"J\u00a0Parenter Enteral Nutr"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/SLA.0000000000003278","article-title":"Direct oral feeding following minimally invasive esophagectomy (NUTRIENT II trial): an international, multicenter, open-label randomized controlled trial","volume":"271","author":"Berkelmans","year":"2020","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib311","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jso.20314","article-title":"Needle catheter jejunostomy at esophagectomy for cancer","volume":"91","author":"Sica","year":"2005","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib312","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/bjs.5283","article-title":"Randomized clinical trial comparing feeding jejunostomy with nasoduodenal tube placement in patients undergoing oesophagectomy","volume":"94","author":"Rodgers","year":"2007","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib313","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11605-012-1887-5","article-title":"Efficacy and complications of nasojejunal, jejunostomy and parenteral feeding after pancreaticoduodenectomy","volume":"16","author":"Gerritsen","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib314","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ejcn.2010.292","article-title":"Nutritional access routes following oesophagectomya systematic review","volume":"65","author":"Markides","year":"2011","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib315","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/SLA.0000000000001325","article-title":"Significance of microscopically incomplete resection margin after esophagectomy for esophageal cancer","volume":"263","author":"Markar","year":"2016","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib316","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/ejcts\/ezt164","article-title":"The impact of positive circumferential margin on survival following oesophagectomy using the new\u00a07th TNM classification","volume":"44","author":"Theologou","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.esmogo.2024.100112_bib317","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1245\/s10434-013-2899-4","article-title":"Lack of independent significance of a close (<1 mm) circumferential resection margin involvement in esophageal and junctional cancer","volume":"20","author":"O'Farrell","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib318","first-page":"138","article-title":"Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study","volume":"113","author":"Fok","year":"1993","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib319","first-page":"123","article-title":"Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial","volume":"173","author":"Teniere","year":"1991","journal-title":"Surg Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1748-717X-8-241","article-title":"Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern","volume":"8","author":"Bao","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib321","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/1471-2407-12-542","article-title":"Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study","volume":"12","author":"Jingu","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib322","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-717X-9-28","article-title":"Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients\u00a0with esophageal squamous cell carcinoma: a phase 2 single-institution study","volume":"9","author":"Ma","year":"2014","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib323","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00066-011-0023-x","article-title":"Salvage radiotherapy in patients with recurrent esophageal carcinoma","volume":"188","author":"Fakhrian","year":"2012","journal-title":"Strahlenther Onkol"},{"issue":"34","key":"10.1016\/j.esmogo.2024.100112_bib324","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1200\/JCO.2013.51.7250","article-title":"Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies","volume":"31","author":"Sudo","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","article-title":"Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials","volume":"32","author":"Oppedijk","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib326","first-page":"1","article-title":"Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road","volume":"30","author":"Depypere","year":"2017","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib327","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-014-3970-5","article-title":"Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy","volume":"22","author":"Hiyoshi","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib328","first-page":"CD001799","article-title":"Preoperative radiotherapy for esophageal carcinoma","volume":"2005","author":"Arnott","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib329","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/107327481302000202","article-title":"Neoadjuvant or adjuvant therapy for resectable esophageal cancer: is there a standard of care?","volume":"20","author":"Almhanna","year":"2013","journal-title":"Cancer Control"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib330","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2008.04.022","article-title":"Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study","volume":"73","author":"Schwer","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"27","key":"10.1016\/j.esmogo.2024.100112_bib331","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.esmogo.2024.100112_bib332","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2407-11-181","article-title":"Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial","volume":"11","author":"Boonstra","year":"2011","journal-title":"BMC Cancer"},{"issue":"30","key":"10.1016\/j.esmogo.2024.100112_bib333","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib334","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal\u00a0cancer: a randomised controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5414\/VDP31251","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"31","author":"Bauer","year":"2013","journal-title":"Verdauungskrankheiten"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib336","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-5223(97)70147-8","article-title":"Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial","volume":"114","author":"Law","year":"1997","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"13","key":"10.1016\/j.esmogo.2024.100112_bib337","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 15","key":"10.1016\/j.esmogo.2024.100112_bib338","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1200\/JCO.2017.35.15_suppl.4004","volume":"35","author":"Al-Batran","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib339","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejca.2015.11.024","article-title":"Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study","volume":"56","author":"Markar","year":"2016","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib341","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/JTO.0000000000000228","article-title":"Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer","volume":"9","author":"Speicher","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib342","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.athoracsur.2013.03.093","article-title":"Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database","volume":"96","author":"Crabtree","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib343","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.21037\/jtd.2017.08.143","article-title":"Should cT2 esophageal cancer get neoadjuvant treatment before surgery?","volume":"9","author":"Thuss-Patience","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.esmogo.2024.100112_bib344","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3389\/fphar.2018.00872","article-title":"Comparative effectiveness of neoadjuvant treatments for resectable gastroesophageal cancer: a network meta-analysis","volume":"9","author":"Cai","year":"2018","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib345","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/gut.2003.025080","article-title":"Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis","volume":"53","author":"Fiorica","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.esmogo.2024.100112_bib346","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.critrevonc.2017.03.024","article-title":"Multimodality treatment of locally advanced squamous cell carcinoma of the oesophagus: a comprehensive review and network meta-analysis","volume":"114","author":"Montagnani","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib347","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/bjs.7455","article-title":"Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer","volume":"98","author":"Kranzfelder","year":"2011","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib348","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10120-018-0901-3","article-title":"Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis","volume":"22","author":"Petrelli","year":"2019","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib349","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00423-023-02862-z","article-title":"Multimodal treatments for resectable esophagogastric junction cancer: a Bayesian network meta-analysis","volume":"408","author":"Shao","year":"2023","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib350","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib351","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00535-011-0448-0","article-title":"Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy","volume":"46","author":"Morita","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"22","key":"10.1016\/j.esmogo.2024.100112_bib352","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.esmogo.2024.100112_bib353","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.esmogo.2024.100112_bib354","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib355","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib356","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MAJ.0000000000000476","article-title":"Concurrent neoadjuvant chemoradiotherapy for siewert II and III adenocarcinoma at gastroesophageal junction","volume":"349","author":"Zhao","year":"2015","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib357","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.esmogo.2024.100112_bib358","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901","volume":"32","author":"Mariette","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib359","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2011.39.1953","article-title":"Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial","volume":"30","author":"Lee","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib360","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ejcts\/ezr182","article-title":"Body mass index kinetics and risk factors of malnutrition one year after radical oesophagectomy for cancer","volume":"41","author":"Ouattara","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib361","first-page":"242","article-title":"Nutrition and physical activity guidelines for cancer survivors","volume":"62","author":"Rock","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib362","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdh219","article-title":"A\u00a0single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma","volume":"15","author":"Lee","year":"2004","journal-title":"Ann Oncol"},{"issue":"27","key":"10.1016\/j.esmogo.2024.100112_bib363","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"10.1016\/j.esmogo.2024.100112_bib364","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3748\/wjg.v16.i13.1649","article-title":"Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma","volume":"16","author":"Lv","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib365","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1067\/msy.2001.110024","article-title":"The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction","volume":"129","author":"Dresner","year":"2001","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib366","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/bjs.5358","article-title":"Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma","volume":"93","author":"Mariette","year":"2006","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib367","first-page":"119","article-title":"Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis","volume":"5","author":"Nagaraja","year":"2014","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib368","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jamcollsurg.2014.11.028","article-title":"Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes","volume":"220","author":"Mariette","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib369","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/a-1475-0063","article-title":"Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021","volume":"53","author":"Spaander","year":"2021","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib370","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doz090","article-title":"Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: a systematic review","volume":"33","author":"Ahmed","year":"2020","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib371","first-page":"10","article-title":"Oesophageal stents for potentially curable oesophageal cancer - a bridge to surgery?","volume":"88","author":"Tham","year":"2019","journal-title":"Ulster Med J"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib372","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doz005","article-title":"Preoperative esophageal stenting and short-term outcomes of surgery for esophageal cancer in a population-based study from Finland and Sweden","volume":"32","author":"Helminen","year":"2019","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib373","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/a-0644-2495","article-title":"Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time","volume":"51","author":"Reijm","year":"2019","journal-title":"Endoscopy"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib374","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","article-title":"Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction","volume":"27","author":"Stahl","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib375","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","article-title":"Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging","volume":"19","author":"Weber","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib376","first-page":"66","article-title":"Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction: commentary","volume":"144","author":"Mariette","year":"2007","journal-title":"J\u00a0Chir (Paris)"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib377","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.soc.2006.07.011","article-title":"Cancer of the gastroesophageal junction: combined modality therapy","volume":"15","author":"Ilson","year":"2006","journal-title":"Surg Oncol Clin N Am"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib378","first-page":"2029","article-title":"Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction","volume":"46","author":"Wieder","year":"2005","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib379","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","article-title":"PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial","volume":"8","author":"Lordick","year":"2007","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib380","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2967\/jnumed.110.085803","article-title":"18F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial","volume":"52","author":"Zum B\u00fcschenfelde","year":"2011","journal-title":"J\u00a0Nucl Med"},{"issue":"25","key":"10.1016\/j.esmogo.2024.100112_bib381","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1200\/JCO.20.03611","article-title":"Randomized phase II study of PET response\u2013adapted combined modality therapy for esophageal cancer: mature results of the CALGB 80803 (Alliance) trial","volume":"39","author":"Goodman","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib382","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/sj.bjc.6603412","article-title":"18FDG uptake during induction\u00a0chemoradiation for oesophageal cancer fails to predict histomorphological tumour response","volume":"95","author":"Gillham","year":"2006","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib383","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1159\/000251842","article-title":"Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75\/02)","volume":"32","author":"Klaeser","year":"2009","journal-title":"Onkologie"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib384","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2967\/jnumed.110.079566","article-title":"Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus","volume":"51","author":"Malik","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib385","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/SLA.0b013e3181f66596","article-title":"Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer","volume":"253","author":"Van Heijl","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib386","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2967\/jnumed.108.054205","article-title":"18F-FDG PET and PET\/CT in the evaluation of cancer treatment response","volume":"50","author":"Ben-Haim","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib387","first-page":"405","article-title":"Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis","volume":"32","author":"Chang","year":"2009","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib388","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/bjs.9437","article-title":"Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy","volume":"101","author":"Karran","year":"2014","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib389","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.1997.15.1.277","article-title":"Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study","volume":"15","author":"al-Sarraf","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"10.1016\/j.esmogo.2024.100112_bib390","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1200\/JCO.2007.12.3471","article-title":"Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9102","volume":"25","author":"Crehange","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib391","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/jjco\/hyp069","article-title":"A\u00a0phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708)","volume":"39","author":"Kato","year":"2009","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib392","first-page":"CD002092","article-title":"WITHDRAWN. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus","volume":"2010","author":"Wong","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib393","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2005.10.015","article-title":"Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma","volume":"64","author":"Yamada","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib394","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/jjco\/hyr069","article-title":"Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer","volume":"41","author":"Kawaguchi","year":"2011","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib395","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10388-008-0158-8","article-title":"Guidelines for diagnosis and treatment of carcinoma of the esophagus","volume":"5","author":"Kuwano","year":"2008","journal-title":"Esophagus"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib396","doi-asserted-by":"crossref","first-page":"81","DOI":"10.21037\/atm.2018.01.31","article-title":"Surveillance versus esophagectomy in esophageal cancer patients with a clinical complete response after induction chemoradiation","volume":"6","author":"Semenkovich","year":"2018","journal-title":"Ann Transl Med"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib397","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/1759-7714.12874","article-title":"Clinical complete response after chemoradiotherapy for carcinoma of thoracic esophagus: is esophagectomy always necessary? A systematic review and meta-analysis","volume":"9","author":"Wang","year":"2018","journal-title":"Thorac Cancer"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib398","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/dote.12146","article-title":"Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus","volume":"27","author":"Gkika","year":"2014","journal-title":"Dis Esophagus"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib399","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hed.23678","article-title":"Cervical esophageal cancer: a population-based study","volume":"37","author":"Grass","year":"2015","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib400","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archotol.126.2.205","article-title":"Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy","volume":"126","author":"Burmeister","year":"2000","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib401","first-page":"830","article-title":"Esophageal and Esophagogastric Junction Cancers v. 2.2018","volume":"9","year":"2017","journal-title":"NCCN"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib402","doi-asserted-by":"crossref","first-page":"855","DOI":"10.5732\/cjc.010.10250","article-title":"Treatment guideline of radiotherapy for Chinese esophageal carcinoma (draft)","volume":"29","author":"Gao","year":"2010","journal-title":"Chin J Cancer"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib403","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2008.08.008","article-title":"Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus","volume":"89","author":"Fenkell","year":"2008","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib404","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1159\/000334194","article-title":"Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer","volume":"34","author":"Ma","year":"2011","journal-title":"Onkologie"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib405","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0360-3016(02)02752-9","article-title":"Improving the consistency in cervical esophageal target volume definition by special training","volume":"53","author":"Tai","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib406","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/bjs.6437","article-title":"Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus","volume":"96","author":"Ott","year":"2009","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib407","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00423-012-0995-8","article-title":"Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction","volume":"398","author":"Panhofer","year":"2013","journal-title":"Langenbecks Arch Surg"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib408","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib409","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijsu.2018.10.037","article-title":"The current optimal multimodality treatments for oesophageal squamous-cell carcinoma: a systematic review and meta-analysis","volume":"60","author":"Li","year":"2018","journal-title":"Int J Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib410","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib411","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","article-title":"Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial","volume":"14","author":"Crosby","year":"2013","journal-title":"Lancet Oncol"},{"issue":"suppl 15","key":"10.1016\/j.esmogo.2024.100112_bib412","doi-asserted-by":"crossref","first-page":"e14508","DOI":"10.1200\/jco.2010.28.15_suppl.e14508","article-title":"Definitive concurrent chemoradiation (CRT) with weekly paclitaxel and carboplatin for patients (pts) with irresectable esophageal cancer: a phase II study","volume":"28","author":"Meerten","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 3","key":"10.1016\/j.esmogo.2024.100112_bib413","doi-asserted-by":"crossref","first-page":"LBA6","DOI":"10.1200\/jco.2014.32.3_suppl.lba6","article-title":"The initial report of RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery","volume":"32","author":"Suntharalingam","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib414","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jtcvs.2021.11.056","article-title":"Bayesian post-hoc analysis of chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"164","author":"Zhou","year":"2022","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"25","key":"10.1016\/j.esmogo.2024.100112_bib415","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib416","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ijrobp.2011.10.053","article-title":"Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer","volume":"83","author":"Kole","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib417","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0360-3016(03)01373-7","article-title":"Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.esmogo.2024.100112_bib418","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1245\/s10434-013-3139-7","article-title":"Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?","volume":"20","author":"Chiu","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib419","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.athoracsur.2011.05.021","article-title":"Does the timing of esophagectomy after chemoradiation affect outcome?","volume":"93","author":"Kim","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11748-008-0337-5","article-title":"Role of salvage esophagectomy after definitive chemoradiotherapy","volume":"57","author":"Tachimori","year":"2009","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib421","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jso.20475","article-title":"Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy","volume":"93","author":"Tomimaru","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib422","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejso.2018.11.002","article-title":"A\u00a0meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy","volume":"45","author":"Faiz","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib423","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.athoracsur.2012.05.106","article-title":"Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma","volume":"94","author":"Marks","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib424","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.02.086","article-title":"Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus","volume":"75","author":"Ariga","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib425","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1245\/s10434-018-6365-1","article-title":"Salvage surgery for esophageal cancer: how to improve outcomes?","volume":"25","author":"Cohen","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib426","first-page":"295","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a phase III, multi-center, randomized controlled trial, Chinese subreport","volume":"35","author":"Shen","year":"2013","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"23","key":"10.1016\/j.esmogo.2024.100112_bib427","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.20.00866","article-title":"Treatment of locally advanced esophageal carcinoma: ASCO guideline","volume":"38","author":"Shah","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib428","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/dote.12043","article-title":"The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer","volume":"27","author":"Morimoto","year":"2014","journal-title":"Dis Esophagus"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib429","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/JTO.0000000000000216","article-title":"Can lymph node ratio replace pn categories in the tumor-node-metastasis classification\u00a0system for esophageal cancer?","volume":"9","author":"Tan","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib430","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1515\/med-2019-0024","article-title":"Prognostic significance of lymph node ratio in ovarian cancer","volume":"14","author":"Tong","year":"2019","journal-title":"Open Med (Poland)"},{"key":"10.1016\/j.esmogo.2024.100112_bib431","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1741-7015-2-35","article-title":"Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario\u2019s Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis","volume":"2","author":"Malthaner","year":"2004","journal-title":"BMC Med"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib432","first-page":"4609","article-title":"Pre- and postoperative treatment modalities for esophageal squamous cell carcinoma","volume":"32","author":"Thallinger","year":"2012","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib433","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.21037\/jtd.2018.06.65","article-title":"The role of postoperative radiotherapy for radically resected esophageal squamous cell carcinoma: a systemic review and meta-analysis","volume":"10","author":"Liu","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib434","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00101-017-0326-0","article-title":"Integration of palliative care into intensive care: systematic review","volume":"66","author":"Adler","year":"2017","journal-title":"Anaesthesist"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib435","first-page":"584","article-title":"Role of postoperative concurrent chemoradiotherapy for esophageal carcinoma: a meta-analysis of 2165 patients","volume":"9","author":"Kang","year":"2018","journal-title":"J\u00a0Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib436","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13014-018-1199-3","article-title":"Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma","volume":"13","author":"Zhang","year":"2018","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib437","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1634\/theoncologist.2019-0276","article-title":"Postoperative radiotherapy in pathological T2\u20133N0M0 thoracic esophageal squamous cell carcinoma: interim report of a prospective, phase III, randomized controlled study","volume":"25","author":"Deng","year":"2020","journal-title":"Oncologist"},{"issue":"47","key":"10.1016\/j.esmogo.2024.100112_bib438","first-page":"e13168","article-title":"Comparison of the effect of postoperative radiotherapy with surgery alone for esophagus squamous cell carcinoma patients a meta-analysis","volume":"97","author":"Zhao","year":"2018","journal-title":"Medicine (United States)"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib439","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.02.008","article-title":"Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis","volume":"86","author":"Ohri","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib440","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00280-010-1256-6","article-title":"A\u00a0randomized phase iii study of adjuvant platinum\/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer","volume":"65","author":"Bamias","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib441","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib442","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1743-7563.2010.01331.x","article-title":"Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection","volume":"6","author":"Kwon","year":"2010","journal-title":"Asia Pac J Clin Oncol"},{"issue":"32","key":"10.1016\/j.esmogo.2024.100112_bib443","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1200\/JCO.2017.74.2130","article-title":"Adjuvant chemoradiotlherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: results from CALGB 80101 (Alliance)","volume":"35","author":"Fuchs","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib444","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","article-title":"A\u00a0randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial","volume":"32","author":"Park","year":"2021","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib445","first-page":"271","article-title":"Benefit of adjuvant chemotherapy for resectable gastric cancer","volume":"16","author":"Paoletti","year":"2011","journal-title":"Clin Gov: Int J"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib446","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"388","author":"Kelly","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 3","key":"10.1016\/j.esmogo.2024.100112_bib447","article-title":"Disease-free and overall survival in nonmetastatic esophageal or gastroesophageal junctional cancer after treatment with curative intent: a nationwide population-based study","volume":"39","author":"Pape","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib448","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jamcollsurg.2010.01.006","article-title":"Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing","volume":"210","author":"Abate","year":"2010","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib449","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40257-020-00502-6","article-title":"Dermatomyositis: an update on diagnosis and treatment","volume":"21","author":"Cobos","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"13","key":"10.1016\/j.esmogo.2024.100112_bib450","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/bjs.11290","article-title":"Phase II randomized clinical trial of endosonography and PET\/CT versus clinical assessment only for follow-up after surgery for upper gastrointestinal cancer (EUFURO study)","volume":"106","author":"Bjerring","year":"2019","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib451","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jand.2012.03.032","article-title":"Suboptimal intake of nutrients after esophagectomy with gastric tube reconstruction","volume":"112","author":"Haverkort","year":"2012","journal-title":"J\u00a0Acad Nutr Diet"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib452","first-page":"doz021","article-title":"Routine placement of feeding jejunostomy tube during esophagectomy increases postoperative complications and does not improve postoperative malnutrition","volume":"33","author":"Koterazawa","year":"2020","journal-title":"Dis Esophagus"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib453","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12092564","article-title":"Needle catheter jejunostomy in patients undergoing surgery for upper gastrointestinal and pancreato-biliary cancer\u2013impact on nutritional and clinical outcome in the early and late postoperative period","volume":"12","author":"Wobith","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib454","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.clnu.2005.12.003","article-title":"Post-oesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a specialist unit","volume":"25","author":"Ryan","year":"2006","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib455","doi-asserted-by":"crossref","first-page":"278","DOI":"10.21037\/apm-20-2197","article-title":"Home enteral nutrition for postoperative elderly patients with esophageal cancer","volume":"10","author":"Chen","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib456","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.clnu.2020.11.023","article-title":"Home enteral nutrition and oral nutritional supplements in postoperative patients with upper gastrointestinal malignancy: a systematic review and meta-analysis","volume":"40","author":"Xueting","year":"2021","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib457","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1188\/13.CJON.559-560","article-title":"Exercise interventions on health-related quality of life for patients with cancer during active treatment","volume":"17","author":"Jing","year":"2013","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib458","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1186\/s12885-021-07989-0","article-title":"Remote interventions to improve exercise behaviour in sedentary people living with and beyond cancer: a systematic review and meta-analysis","volume":"21","author":"Ibeggazene","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib459","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3912\/OJIN.Vol18No03CRBCol03","article-title":"Cochrane review brief: exercise interventions on health-related quality of life for cancer survivors","volume":"18","author":"Kirshbaum","year":"2013","journal-title":"Online J Issues Nurs"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib460","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib461","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1997.15.1.261","article-title":"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer","volume":"15","author":"Webb","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.esmogo.2024.100112_bib462","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1200\/JCO.2002.08.105","article-title":"Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer","volume":"20","author":"Ross","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib463","first-page":"65","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group \u2013 commentary","volume":"144","author":"Mariette","year":"2007","journal-title":"J\u00a0Chir (Paris)"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib464","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2009.25.4706","article-title":"Multicenter phase III comparison of cisplatin\/S-1 with cisplatin\/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial","volume":"28","author":"Ajani","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib465","unstructured":"Belgian Health Care Knowledge Center (KCE). Clinical practice guidelines upper gastrointestinal cancer. Available at https:\/\/kce.fgov.be\/nl\/publicaties\/alle-rapporten\/update-van-de-praktijkrichtlijn-voor-slokdarm-en-maagkanker, Published 2012. Accessed January 12, 2023."},{"issue":"17","key":"10.1016\/j.esmogo.2024.100112_bib466","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2008.19.1718","article-title":"Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie","volume":"27","author":"Goekkurt","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib467","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/annonc\/mdn717","article-title":"Capecitabine\/cisplatin versus 5-fluorouracil\/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial","volume":"20","author":"Kang","year":"2009","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib468","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/annonc\/mdp047","article-title":"Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer","volume":"20","author":"Okines","year":"2009","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.esmogo.2024.100112_bib469","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2007.11.1666","article-title":"Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU\/FA), or HD-FU\/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European organisation for research and treatment of cancer gastroi","volume":"25","author":"Lutz","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib470","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/annonc\/mdn403","article-title":"Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie","volume":"19","author":"Al-batran","year":"2008","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib471","doi-asserted-by":"crossref","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","article-title":"Esophageal and esophagogastric junction cancers, Version 2.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Ajani","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"31","key":"10.1016\/j.esmogo.2024.100112_bib472","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/JCO.2013.54.1011","volume":"32","author":"Guimbaud","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib473","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000335585","article-title":"A\u00a0phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer","volume":"58","author":"Xiang","year":"2012","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib474","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10120-012-0204-z","article-title":"A\u00a0phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases","volume":"16","author":"Catalano","year":"2013","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib475","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ejca.2012.09.025","article-title":"The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)","volume":"49","author":"Al-Batran","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib476","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/bjc.2016.442","article-title":"A\u00a0randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)","volume":"116","author":"Hall","year":"2017","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib477","first-page":"CD004063","article-title":"Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer","volume":"11","author":"Janmaat","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10302","key":"10.1016\/j.esmogo.2024.100112_bib478","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(21)01234-4","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study","volume":"398","author":"Sun","year":"2021","journal-title":"Lancet"},{"issue":"10294","key":"10.1016\/j.esmogo.2024.100112_bib479","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"10418","key":"10.1016\/j.esmogo.2024.100112_bib480","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib481","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S1470-2045(18)30481-9","article-title":"Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study","volume":"19","author":"Tabernero","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib482","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1470-2045(17)30111-0","article-title":"Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2\/3 study","volume":"18","author":"Thuss-Patience","year":"2017","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib483","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa2111380","article-title":"Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma","volume":"386","author":"Doki","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib484","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.2021.12836","article-title":"Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial","volume":"326","author":"Luo","year":"2021","journal-title":"J\u00a0Am Med Assoc"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib485","first-page":"524","article-title":"Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model","volume":"244","author":"Adam","year":"2006","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.esmogo.2024.100112_bib486","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/JTO.0b013e318183aa0c","article-title":"Disease-free interval length correlates to prognosis of patients who underwent metastasectomy\u00a0for esophageal lung metastases","volume":"3","author":"Shiono","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib487","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00268-012-1830-7","article-title":"Pattern of postoperative recurrence and hepatic and\/or pulmonary resection for liver and\/or lung metastases from esophageal carcinoma","volume":"37","author":"Ichida","year":"2013","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib488","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/jso.21353","article-title":"Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer","volume":"100","author":"Miyata","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib489","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.athoracsur.2012.10.028","article-title":"Salvage resections for recurrent or persistent cancer of the proximal esophagus after chemoradiotherapy","volume":"95","author":"Schieman","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"15","key":"10.1016\/j.esmogo.2024.100112_bib490","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.ejca.2011.06.002","article-title":"Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer \u2013 a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)","volume":"47","author":"Thuss-Patience","year":"2011","journal-title":"Eur J Cancer"},{"issue":"35","key":"10.1016\/j.esmogo.2024.100112_bib491","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1200\/JCO.2012.48.5805","article-title":"Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 tria","volume":"31","author":"Hironaka","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib492","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(13)70549-7","article-title":"Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial","volume":"15","author":"Ford","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9911","key":"10.1016\/j.esmogo.2024.100112_bib493","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for\u00a0previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib494","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial","volume":"15","author":"Wilke","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib495","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S1470-2045(18)30739-3","article-title":"Trifluridine\/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"19","author":"Shitara","year":"2018","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib496","first-page":"1571","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"J\u00a0Am Med Assoc Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib497","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/cncr.34019","article-title":"Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): a randomized, open-label, phase 3 trial in Asian patients","volume":"128","author":"Chung","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib498","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10120-021-01227-z","article-title":"Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial","volume":"25","author":"Fuchs","year":"2022","journal-title":"Gastric Cancer"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib499","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1470-2045(23)00215-2","volume":"24","author":"Van Cutsem","year":"2023","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.esmogo.2024.100112_bib500","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa2004413","article-title":"Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer","volume":"382","author":"Shitara","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib501","first-page":"546","article-title":"Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: the phase 2 KEYNOTE-180 study","volume":"5","author":"Shah","year":"2019","journal-title":"J\u00a0Am Med Assoc Oncol"},{"issue":"15","key":"10.1016\/j.esmogo.2024.100112_bib502","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1158\/1078-0432.CCR-21-0985","article-title":"Three-year follow-up and response-survival relationship of nivolumab in previously treated patients with advanced esophageal squamous cell carcinoma (ATTRACTION-3)","volume":"28","author":"Okada","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.esmogo.2024.100112_bib503","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.21.01926","article-title":"Tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma (RATIONALE-302): a randomized phase III study","volume":"40","author":"Shen","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib504","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S1470-2045(20)30110-8","article-title":"Camrelizumab versus investigator\u2019s choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study","volume":"21","author":"Huang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib505","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/0284186X.2012.731521","article-title":"Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review","volume":"52","author":"Amdal","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.esmogo.2024.100112_bib506","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2407-12-70","article-title":"Survival after chemotherapy and\/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study","volume":"12","author":"Sgourakis","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib507","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12029-010-9206-4","article-title":"Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial","volume":"43","author":"Javed","year":"2012","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.esmogo.2024.100112_bib508","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of Obesity: A National Clinical Guideline. Sign 115. Available at https:\/\/www.sign.ac.uk\/assets\/sign115.pdf, Published 2010. Accessed January 12, 2023."},{"issue":"9444","key":"10.1016\/j.esmogo.2024.100112_bib509","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib510","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.radonc.2010.09.001","article-title":"Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency","volume":"97","author":"Rosenblatt","year":"2010","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib511","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s10620-010-1250-1","article-title":"The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and meta-regression analysis of outcomes","volume":"55","author":"Sgourakis","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib512","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/gut.52.7.922","article-title":"A\u00a0randomised prospective comparison of the flamingo wallstent and ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma","volume":"52","author":"Sabharwal","year":"2003","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib513","first-page":"1","article-title":"A\u00a0pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer","volume":"9","author":"Shenfine","year":"2005","journal-title":"Health Technol Assess (Rockv)"},{"issue":"6","key":"10.1016\/j.esmogo.2024.100112_bib514","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1572-0241.2001.03923.x","article-title":"A\u00a0prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction","volume":"96","author":"Vakil","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.esmogo.2024.100112_bib515","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/a-0620-8135","article-title":"Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study)","volume":"50","author":"Didden","year":"2018","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib516","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1051-0443(95)71105-8","article-title":"Malignant esophageal stricture and fistula: palliative treatment with polyurethane-covered gianturco stent","volume":"6","author":"Miyayama","year":"1995","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib517","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0003-4975(00)02679-5","article-title":"Evolving management and outcome of esophageal cancer with airway involvement","volume":"71","author":"Alexander","year":"2001","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib518","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1111\/j.1572-0241.2007.01565.x","article-title":"A\u00a0randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia","volume":"102","author":"Conio","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib519","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4253\/wjge.v11.i4.272","article-title":"Efficacy and safety of standard and anti-reflux self-expanding metal stent: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Pandit","year":"2019","journal-title":"World J Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib520","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.gie.2019.01.013","article-title":"A\u00a0phase III, multicenter, prospective, single-blinded, noninferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video)","volume":"90","author":"Dua","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib521","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/lap.2020.0666","article-title":"Radioactive stent for malignant esophageal obstruction: a meta-analysis of randomized controlled trials","volume":"31","author":"Yang","year":"2021","journal-title":"J\u00a0Laparoendosc Adv Surg Tech A"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib522","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1634\/theoncologist.2017-0646","article-title":"Esophageal metal stents with concurrent chemoradiation therapy for locally advanced esophageal cancer: safe or not?","volume":"23","author":"Lu","year":"2018","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib523","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.gie.2017.09.020","article-title":"Self-expandable metal stent for malignant esophagorespiratory fistula: predictive factors associated with clinical failure","volume":"87","author":"Ribeiro","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"4C","key":"10.1016\/j.esmogo.2024.100112_bib524","first-page":"2705","article-title":"Palliative chemotherapy for recurrent and metastatic esophageal cancer","volume":"27","author":"Gr\u00fcnberger","year":"2007","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib525","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S2468-1253(21)00004-2","article-title":"Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial","volume":"6","author":"Adamson","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib526","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1442-2050.2005.00467.x","article-title":"Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial","volume":"18","author":"Bergquist","year":"2005","journal-title":"Dis Esophagus"},{"issue":"12","key":"10.1016\/j.esmogo.2024.100112_bib527","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00042737-200512000-00017","article-title":"Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial","volume":"17","author":"Wenger","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.esmogo.2024.100112_bib528","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1442-2050.2011.01248.x","article-title":"Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer \u2013 results of a prospective safety study","volume":"25","author":"Bergquist","year":"2012","journal-title":"Dis Esophagus"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib529","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/110241599750006893","article-title":"Endoscopic palliation of oesophageal cancer: results of a prospective comparison of Nd:YAG laser and ethanol injection","volume":"165","author":"Carazzone","year":"1999","journal-title":"Eur J Surg"},{"issue":"2","key":"10.1016\/j.esmogo.2024.100112_bib530","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/gut.50.2.224","article-title":"Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study","volume":"50","author":"Spencer","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib531","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1442-2050.1999.00029.x","article-title":"Endoscopic palliation of esophageal and cardial cancer: neodymium-yttrium aluminum garnet laser therapy","volume":"12","author":"Norberto","year":"1999","journal-title":"Dis Esophagus"},{"issue":"5 Part 1","key":"10.1016\/j.esmogo.2024.100112_bib532","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0016-5085(91)70017-R","article-title":"A\u00a0prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia","volume":"100","author":"Loizou","year":"1991","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.esmogo.2024.100112_bib533","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/bjs.1800791120","article-title":"Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia: a randomized prospective study","volume":"79","author":"Carter","year":"1992","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib534","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.31.3.252","article-title":"Prospective randomised trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia","volume":"31","author":"Barr","year":"1990","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.esmogo.2024.100112_bib535","first-page":"352","article-title":"The tissue effect of second generation argon plasma coagulation (VIO APC) in comparison to standard APC and Nd:YAG laser in\u00a0vitro","volume":"70","author":"Manner","year":"2007","journal-title":"Acta Gastroenterol Belg"},{"issue":"7","key":"10.1016\/j.esmogo.2024.100112_bib536","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-2007-966571","article-title":"Prospective nonrandomized comparison of two modes of argon beamer (APC) tumor desobstruction: effectiveness of the new pulsed APC versus forced APC","volume":"39","author":"Eickhoff","year":"2007","journal-title":"Endoscopy"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib537","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00365520600898130","article-title":"Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy","volume":"42","author":"Manner","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.esmogo.2024.100112_bib538","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.esmoop.2023.102202","article-title":"Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study","volume":"9","author":"Ajani","year":"2024","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib539","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.gie.2018.04.2362","article-title":"Liquid nitrogen spray\u00a0cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer","volume":"88","author":"Kachaamy","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.esmogo.2024.100112_bib540","first-page":"442","article-title":"Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II)","volume":"27","author":"Rupinski","year":"2012","journal-title":"Dysphagia"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819824000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819824000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T03:20:30Z","timestamp":1753327230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819824000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":539,"alternative-id":["S2949819824000736"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2024.100112","relation":{},"ISSN":["2949-8198"],"issn-type":[{"type":"print","value":"2949-8198"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus\u2014version 4.0","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2024.100112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100112"}}